Efficient Differentiation of Embryonic Stem Cells into Hepatic Cells In Vitro Using a Feeder-Free Basement Membrane Substratum by Shiraki, Nobuaki et al.
Efficient Differentiation of Embryonic Stem Cells into
Hepatic Cells In Vitro Using a Feeder-Free Basement
Membrane Substratum
Nobuaki Shiraki
1,2, Taiji Yamazoe
1,2, Zeng Qin
3, Keiko Ohgomori
3, Katsumi Mochitate
3, Kazuhiko
Kume
1,2, Shoen Kume
1,2*
1Department of Stem Cell Biology, Institute of Molecular Embryology and Genetics, Kumamoto University, Honjo, Kumamoto, Japan, 2Global Center of Excellence
Program, Kumamoto University, Honjo, Kumamoto, Japan, 3BM Matrix Laboratory, Environmental Health Sciences Division, National Institute for Environmental Studies,
Ibaraki, Japan
Abstract
The endoderm-inducing effect of the mesoderm-derived supportive cell line M15 on embryonic stem (ES) cells is partly
mediated through the extracellular matrix, of which laminin a5 is a crucial component. Mouse ES or induced pluripotent
stem cells cultured on a synthesized basement membrane (sBM) substratum, using an HEK293 cell line (rLN10-293 cell)
stably expressing laminin-511, could differentiate into definitive endoderm and subsequently into pancreatic lineages. In
this study, we investigated the differentiation on sBM of mouse and human ES cells into hepatic lineages. The results
indicated that the BM components played an important role in supporting the regional-specific differentiation of ES cells
into hepatic endoderm. We show here that knockdown of integrin b1( Itgb1) in ES cells reduced their differentiation into
hepatic lineages and that this is mediated through Akt signaling activation. Moreover, under optimal conditions, human ES
cells differentiated to express mature hepatocyte markers and secreted high levels of albumin. This novel procedure for
inducing hepatic differentiation will be useful for elucidating the molecular mechanisms controlling lineage-specific fates
during gut regionalization. It could also represent an attractive approach to providing a surrogate cell source, not only for
regenerative medicine, but also for pharmaceutical and toxicologic studies.
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Introduction
The liver is an essential organ responsible for many kinds of
metabolism, as well as for the storage of essential nutrients, the
production and secretion of albumin (ALB), and biotransformation
of xenobiotics. Biotransformation of xenobiotics usually results in
their detoxification, but can also induce their bioactivation, if the
metabolites produced are more toxic than their parent drug
molecule. Although primary hepatocyte culture is a powerful tool
for studying the bioactivation of xenobiotics, the hepatic function
is inclined to be reduced in culture. In addition, bioactivation
varies considerably depending upon the characteristics of the
donors.
Embryonic stem (ES) cells are pluripotent cells derived from the
inner cell mass of the blastocyst. In vitro approaches to inducing
their differentiation into hepatic lineages involves the formation of
embryoid bodies to mimic the inductive microenvironment
required for liver organogenesis [1,2], or their treatment with
specific growth factors and cytokines critical for hepatocyte
differentiation [3]. Co-cultivation of ES cells with embryonic
mesenchymal cells has also been shown to direct ES cells towards a
hepatic lineage [4,5,6]. Bone morphogenetic protein 4 (BMP4) was
shown to induce the in vitro generation of mouse ES cell-derived
hepatic cells [7]. The differentiation of human ES cells into
hepatocytes has been shown using stage wise processes. Recent
studies demonstrated that extrinsic signaling molecules Activin/
Nodal direct differentiation into the definitive endoderm, fibro-
blast growth factor (FGF) plus BMP produce potentiated
differentiation into hepatic lineage of human ES cells, retinoic
acid (RA), Wnt 3a and dimethyl sulfoxide (DMSO) increase
hepatic differentiation in human ES cells, then Hepatocyte growth
factor (HGF) and Oncostatin M (OSM) promote maturation of
hepatocytes [8,9,10,11,12,13,14]. Actually, these signaling mole-
cules have been shown to function during embryonic development
of the liver, therefore, ES cells are considered to recapitulate many
aspects of normal developmental processes and serve as an
attractive system for studies of developmental biology, applications
for innovative drug screening strategies and regenerative medicine
[15,16,17,18].
We previously reported that the mesonephric cell line, M15,
had the ability to induce ES cells into pancreatic or hepatic
lineages in vitro [10,11]. Under selective culture conditions,
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differentiate intoa-fetoprotein (AFP)-positive cells, and 9% of total
cells turned into ALB-positive cells; only the final stage of
differentiation into regional-specific definitive endoderm required
direct contact with M15 cells. The fact that even the fixed M15
cell layer retained the ability to induce pancreatic differentiation
[10], suggested that the basement membrane (BM) components
played a key role in guiding differentiation into regional-specific
lineages of the definitive endoderm.
The BM has a highly integrated structure composed of
extracellular matrix (ECM) molecules. The major components of
most BMs are type IV collagen, laminins (LNs), entactin (nidogen)
and heparin sulfate proteoglycans (HSPGs), such as perlecan.
These molecules, together with secreted cytokines, are derived
either from the epithelial cells, or from the surrounding
mesenchymal cells, and are integrated into the structure of the
BM [19,20]. The molecules are then assembled to form an optimal
extracellular environment for developing, regenerating or matur-
ing cells. M15 cells expressed high levels of LN a5( Lama5), relative
to OP9 and PA6 cells, which showed no endodermal-inducing
activities [21]. Lama5 knockdown of M15 cells reduced their
endodermal differentiation potential, thus indicating that Lama5 is
one of the components responsible for mediating the differentia-
tion potency of M15.
The ECM is regarded as one of the important parameters for
cell differentiation [22]. For human ES cells, which predominantly
express integrin a6b1, recombinant LN332, LN511 and LN111
were shown to serve as good substrates to expand undifferentiated
human ES cells [23]. Three dimensional scaffolds such as matrigel
or collagen were shown to be effective in inducing hepatocyte
differentiation from human ES cells when added with hepatocyte
growth factor in vitro [24,25]. Other three dimensional fibrous
scaffolds and spheroid foams made from polyesters have been
shown to support hepatic differentiation of mouse ES cells in the
presence of specific growth factors [26,27].
We recently reported a novel approach for directing ES cell
differentiation on a solid environment of BM, without the need for
an M15 feeder layer [21]. We described a synthesized BM (sBM)
substratum using an HEK293 cell line stably expressing human
recombinant LN-511 (rLN511 sBM), into which rLN-10 cells [28]
secreted and integrated the BM components. Using this sBM
substratum, mouse ES cells or induced pluripotent stem (iPS) cells
were differentiated into definitive endoderm and further into
pancreatic lineages [21]. In this study, we investigated the ability of
the sBM substratum to also support the hepatic differentiation of
both mouse and human ES cells.
Results
ES cells grown on rLN511-sBM substratum could
differentiate into AFP-expressing hepatic progenitor cells
and functional ALB-secreting hepatocytes
We thus prepared a sBM substratum of human recombinant
LN511 (rLN511 sBM), into which rLN-10 cells [28] secreted and
integrated the BM components.
For hepatic differentiation, the mouse SK7 ES cell line was
seeded onto the rLN511 sBM substratum and cultured with serial
change of media shown in Figure 1A. The expressions of
mesenendoderm markers (T and Gsc), definitive endoderm
markers, (Mixl1, Sox17 and Foxa2) and hepatic endoderm markers
(Hex, Hnf4a, Hnf6) were observed by day 11 (D11) of differenti-
ation. The hepatic progenitor markers (a-fetoprotein; Afp) were
expressed from D20. Markers that were specific for mature
hepatocytes, such as albumin (Alb), a1-antitrypsin (aAT), Cyp3a11 and
Cyp7a1, were expressed from D20 or D30 (Fig. 1B). The
differentiation of ES cells into the definitive endoderm (DE) was
quantified by flow cytometry, showing an increase with time from
day 5 (D5) to D9 of differentiation, and that 40% of cells
differentiated into E-cadherin-positive, CXCR4-positive DE cells
on D9 (Fig. 1C). Negative control stained with isotype controls of
the CXCR4 and the E-Cadherin was confirmed to give no signals
(Fig. S1). Quantitative reverse transcription-polymerase chain
reaction (RT-PCR) analysis revealed that Afp was expressed at a
high level on D18, and decreased thereafter, while expression of
the hepatocyte marker, Alb, was detectable from D18, and
increased thereafter. The levels of Afp and Alb transcripts on
differentiation D18 and D30, respectively, were comparable to the
levels in fetal liver (FL) (Fig. 1D). Immunocytochemical analyses
indicated that both AFP and ALB proteins were present in the
cytoplasm (Fig. 1E). Some of the ALB-positive cells were binuclear
(Fig. 1E, arrowheads), which is a characteristic of mature
hepatocytes. Quantitative measurements revealed that approxi-
mately 2264% of cells were AFP-positive at D18, which decreased
to 362% at D30, whereas 562% of cells were ALB-positive at
D18, which increased to 4566% at D30 (Fig. 1E). ALB secretion
could be detected from D18, which increased with days and
reached a rate of 6.8 mg/day/mg protein at D30. Taking into
account that 4566% cells expressed ALB, the ALB secretion
ability of the ALB-positive cells was approximately comparable to
that of the adult mouse primary hepatocytes (Fig. 1F, pHep).
Here, we cultured ES cells on sBM and differentiation was done
under novel culture conditions compared to our previous report
[11]. To clarify the differences, we compared ALB secretion levels
yielded among different differentiation conditions. Differentiation
performed on sBM yielded a 1.5-fold increase in ALB secretion
level compared to that grown on M15 cells. Addition of RA,
nicotinamide (NA) and DMSO further yielded a 21-fold increase
in ALB secretion and yielded Albumin secretion 6.8 mg/day/mg
protein (Table S2).
Taken together, the above results indicated that the sBM
substratum served as a suitable solid environment of extracellular
matrix structure with the potential to guide mouse ES cell
differentiation into the hepatic lineage, secreting ALB at a level
comparable to that of the mature adult hepatocytes.
Differentiation of ES cells on sBM is mediated through
integrin b1
We previously showed that BM components play an important
role in the differentiation of definitive endoderm lineages, and that
Lama5 is one of the key guiding signals in the sBM [21]. Also, we
showed that Lama5 signaling in ES cells is mediated through
integrin-b1 (Itgb1), which is known to interact with LNs. We
performed Itgb1 knockdown in differentiating ES cells to determine
if Itgb1 also mediates extracellular guiding signals in ES cells in the
case of hepatic differentiation. To evaluate the knockdown
efficiency, we transfected Itgb1-knockdown lentivirus (Itgb1 KD)
to undifferentiated ES cells and established an Itgb1KD ES cell
line. Itgb1KD ES cells showed a decreased Itgb1 expression level,
compared to non-specific shRNA transfected (NS) ES cells
(Fig.2A). The decrease in Itgb1 protein level was confirmed by
flow cytometry analysis, and the mean fluorescence intensity
decreased to less than 1/20 fold (Fig. 2B, C). Since Itgb1KD ES
cells showed a decreased attachment to the plate, we then added
the Itgb1KD to ES cell cultures on D9, followed by puromycin
selection for one day on D10 to enrich lentivirus-transduced cells
(Fig. 2D). The dose response for assessing cell death by graded
concentrations of puromycin was performed empirically to ensure
the enrichment of the Itgb1KD transfected ES cells (Fig. S2). The
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PLoS ONE | www.plosone.org 2 August 2011 | Volume 6 | Issue 8 | e24228Figure 1. Differentiation of mouse ES cells into definitive endoderm and cells of the hepatic lineage on sBM. (A) Schematic of the
experimental procedure. Mouse ES cells (mES) were differentiated on day (D) 0–9 in serum-free DMEM supplemented with ITS, 20 ng/ml activin and
50 ng/ml bFGF. RA 1 mM was added to the differentiation medium at D9–11. At D11, the supplements were changed to 1 mM Dex, 10 ng/ml HGF, 1%
DMSO and 1 mM NA in KSR-DMEM. (B) Lineage-specific molecular marker expression in undifferentiated ES cells (ES), differentiated ES cells grown on
sBM on D5, 9, 11, 20 and 30, Fetal liver (FL) and Adult liver (AL). (C) Flow cytometry of differentiated ES cells on sBM on D5, D7 and D9. Forty percent
of total ES cell-culture area consisted of E-cadherin
+/CXCR4
+ definitive endoderm cells. Values represent means 6 S.E.M (N=3). (D) Relative
expression levels of hepatic marker genes, Afp (alpha fetoprotein, gray bars) and Alb (albumin, black bars) in differentiated ES cells at D11, D18, D24,
D30 and in fetal liver were quantified by real-time PCR analyses. The expression levels were normalized to that of b-actin. FL: E12.5 fetal liver. Values
represent means 6 S.E.M (N=3). (E) ES cells differentiated for 18 or 30 days were stained for AFP (Alpha-fetoprotein; green) or ALB (Albumin; red),
and counterstained with DAPI (blue). Percentages indicated in green or red are the positive cells for AFP or ALB, respectively. Arrowheads indicate
binuclear hepatocyte-like cells. Scale bars =100 mM. Values represent means 6 S.E.M (N=3). (F) A diagram of the ES cell-derived hepatic cells grown
on sBM and samples used for Albumin (ALB) secretion assay. Albumin secretion by mouse ES cell-derived hepatic cells was assayed by ELISA. The
differentiation medium was changed to fresh medium 24 hrs before the assay. The amount of ALB released from the ES cell-derived hepatic cells into
the medium per 24 hrs per mg protein was measured on day (D) 11, D18, D24 and D30 of differentiation on sBM. Albumin secretion level was
normalized with total protein. Values represent means 6 S.E.M (N=3).
doi:10.1371/journal.pone.0024228.g001
Hepatic Differentiation of ES Cells on BM
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e24228Figure 2. Differentiation of ES cells into hepatic lineages on sBM is mediated through integrin b1. (A) Real-time PCR analysis of Itgb1
expression in NS or Itgb1 KD ES cells. Significant differences were observed (**p,0.01) versus NS. Values represent means 6 S.E.M (N=3). (B) Flow
cytometry analysis of Itgb1 expression in NS (green line) or Itgb1 KD (red line) ES cells. Black line indicated unstained samples. (C) Mean fluorescence
intensity of Itgb1 in NS or Itgb1 KD undifferentiated ES cells. Significant differences were observed (**p,0.01) versus NS. Values represent means 6
S.E.M (N=3). (D) ES cells were cultured as described in Fig. 1 and non-silencing (NS) or Itgb1-knockdown (Itgb1 KD) lentivirus-containing medium was
added on day (D) 9. Puromycin selection from D10 to D11 was used to remove uninfected cells. Cells were analyzed on D18. (E, F) Real-time PCR
analysis of Itgb1 and Afp expression in NS or Itgb1 KD ES cells. Total RNA was extracted on D18. Itgb1 and Afp expression were normalized to that of b-
actin. Significant differences were observed (**p,0.01) versus NS. Values represent means 6 S.E.M (N=3). (G) Western blot analysis of phospho-Akt,
Akt and GAPDH in the Intgb1 KD or control (NS) cells. GAPDH is used as an internal control for total proteins. The phosphorylation level of Akt was
Hepatic Differentiation of ES Cells on BM
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hepatic lineage differentiation was assayed by detection of Afp
transcripts. Itgb1 KD cells expressed a decreased level of Itgb1
transcripts approximately 1/10-fold of the non-silencing negative
control samples (NS) (Fig. 2E), and yielded a reduced level of Afp
transcripts approximately 1/10-fold of the control (Fig. 2F).
The serine-threonine kinase Akt (protein kinase B / PKB) was
known as one of a downstream molecule of integrin signals [29].
Western blot analysis revealed that phosphorylation of Akt was
inhibited in Itgb1 KD cells (D11) (Fig. 2G), thereby suggesting that
Akt lying downstream of Itgb1 signaling here. A cell-permeable
potent Akt inhibitor benzimidazole compound [30] was added
from D9 to D18, and Afp transcript level decreased to 1/5-fold of
the control (Fig. 2H). These results suggest that the extracellular
signals from the sBM guiding ES cells differentiation into the
hepatic lineage is transduced through the Itgb1-Akt signaling
pathway.
Human ES cells could differentiate into hepatic lineages
on sBM
We also determined the ability of the sBM to allow the
differentiation of human ES cells. The human KhES-3 ES cell line
was cultured on sBM, and the expression of the definitive
endoderm marker, Sox17, was observed on D10 differentiation
(Fig. 3A, B). By D30 of differentiation, KhES-3 cells had formed a
monolayer of polygonal cells, including some binuclear cells,
which is a characteristic of mature hepatocytes (Fig. 3C,
arrowheads). The expression level of Afp transcripts was high on
D20, but had decreased on D30. Alb transcripts were detected
from D20, and had increased on D30, but the level remained
lower than that in human fetal (FL) or adult liver (AL) (Fig. 3D).
Immunocytochemical analyses show AFP expression on D20 and
ALB cytoplasmic staining on D30 (Fig. 3E, F). The hepatic cells
expressing ALB were also positive for a-antitrypsin. These results
demonstrate that sBM allowed the differentiation of human ES
cells into hepatic lineages.
Human ES cells grown on sBM differentiated in vitro into
hepatic cells expressing mature hepatocyte markers and
secreting albumin
Regarding the expression of other mature hepatocyte markers,
substantial levels of Cytochrome P450 3A4 (CYP3A4), Cyto-
chrome P450 7A1 (CYP7A1), Na+-taurocholate cotransporting
polypeptide (NTCP), Organic anion transporting polypeptides
2B1 (OATP2B1), Sulfotransferase 2A1 (SULT2A1) and UDP
glucuronosyltransferase 1A1 (UGT1A1) transcripts were detected
in differentiated KhES-3 cells at D30 (Fig. 4A). Except OATP2B1,
these markers were absent from fetal liver, thereby indicating that
the ES cell-derived hepatic cells expressed mature hepatocyte
markers. ALB secretion was detected in human ES cell-derived
hepatocytes from D20, and reached a peak of approximately
2.9 mg/day/mg protein at D30 (Fig. 4B). Hepatocytes derived
from human ES cells incorporated indocyanine green (ICG) (Fig.
4C, left panel), which was excluded after 24 hrs (Fig. 4C, right
panel). These cells were also periodic acid-Schiff (PAS)-positive,
indicating cytoplasmic glycogen storage (Fig. 4D). The primary
bile acid analog cholyl lysyl fluorescein (CLF), which is a substrate
for the excretion transporter [31], was rapidly taken up and
transported into bile canaliculi, indicating that functional trans-
porters were expressed in the human ES cell-derived hepatocytes
(Fig. 4E). These cells expressed high levels of CYP3A4 transcripts
(Fig. 4F, left panel) and showed CYP3A4 enzymatic activity (Fig.
4D, right panel), both of which were induced by rifampicin
treatment.
Overall, these results indicate that human ES cells grown on
sBM were able to differentiate into hepatic cells expressing mature
hepatocyte markers and secreting albumin.
Discussion
Previous studies suggested that the addition of soluble growth
factors was sufficient to support the differentiation of ES cells into
definitive endoderm. However, direct contact between ES cells
and M15 cells was necessary for the progression of regional-
specific differentiation into endodermal tissues [10]. We also
reported the development of a sBM by culturing HEK293 cells
overexpressing rLN511 (LNa5, b1 and c1) (rLN511 sBM), which
could be used to allow the subsequent differentiation of ES cells or
iPS cells into pancreatic lineages, and further into insulin-
expressing endocrine cells [21]. The pancreatic differentiation
signal was mediated by the components of the BM, including LN
a5 and HSPGs. In the current study, we demonstrated that the
sBM was also able to support the hepatic-lineage differentiation of
ES cells, and that Itgb1 plays a role in mediating hepatic
differentiation. The efficacy of hepatic differentiation on sBM
was high, and the derived differentiated cells were able to further
differentiate into hepatic cells expressing mature hepatocyte
markers and secreting ALB. This procedure was applicable to
both mouse and human ES cells. The ES cell-derived hepatic cells
were induced to sequentially express T, Gsc, Mixl1, Sox17, Foxa2,
Hex, Hnf4a, Hnf6, Afp and Alb, recapitulating the normal
developmental processes. These ES cell-derived hepatic cells
expressed mature hepatocyte markers aTT , Cyp3a11 and Cyp7a1.
These results indicate that although the ES cell-derived hepatic
cells expressed Alb transcripts at a much lower level, they showed
transcriptional profiles of the mature hepatocytes. Human ES-
derived hepatic cells exhibited several mature hepatic profiles,
such as ALB secretion, uptake and export of ICG and CLF,
glycogen storage, and CYP3A4 metabolic enzyme activity.
The Itgb1 KD experiment demonstrated that the guiding signal
from sBM was transduced through Itgb1, which functions as a key
component in the differentiation of ES cells into the hepatic
lineage. Integrins bind the ECM as heterodimers consisting of
different combinations of a and b subunits. Itgb1 is a cell surface
receptor that mediates cell-matrix and cell-cell interactions.
Epithelial cells derived from endodermal gut tubes, such as lung,
esophagus, trachea, stomach, hindgut and urinary bladder, all
express Itgb1 [32]. During hepatic development, Itgb1 is
expressed in the mouse early foregut endoderm at embryonic
development day (E)9.5 exclusively in Afp-expressing cells, and
later at E17.5 in blood vessels in sinusoidal structures [33]. Itgb1
mutant mice were reported to die early in development, prior to
the onset of hepatogenesis [34], while analysis of chimeric mice,
generated by combining wild-type embryos with Itgb1 mutant ES
cells, revealed that cells lacking Itgb1 were incapable of colonizing
the liver. This result implies that there is a cell autonomous
requirement for Itgb1 in defining or maintaining the hepatic cell
lineage [34]. Moreover, Itgb1 levels in Smad2
+/- and Smad3
+/-
mutant mice, in which liver architecture was disrupted and the
significantly reduced in Intgb1 KD but not in NS cells (N=2). (H) Real-time PCR analysis of Afp expression in Akt inhibitor treated cells on D18.
Significant differences were observed (*p,0.05) versus NS. Values represent means 6 S.E.M (N=3).
doi:10.1371/journal.pone.0024228.g002
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e24228Figure 3. Human ES KhES-3 cells differentiated into hepatic cells on the sBM substratum. (A) Human ES cells were differentiated at D0–10
in serum-free medium supplemented with 100 ng/ml activin. At D10, the supplements were switched to 1 mM Dex, 10 ng/ml HGF, 0.5% DMSO,
0.5 mM NA and 0.2 mM AsP. (B) KhES-3 cultured for 10 days were stained for Sox17 (red), and counterstained with DAPI (blue). Scale bars =100 mM.
(C) KhES-3 cells on D30 (unstained). Polygonal cells were observed (arrowheads). (D) Relative expression levels of Afp (alpha fetoprotein; gray bars) and
Alb (albumin; black bars) in differentiated KhES-3 cells at day (D) 10, D20, and D30, and in human fetal (FL) and adult liver (AL) were quantified by real-
time PCR analyses. The expression levels were normalized to that of glyceraldehyde phosphate 3-dehydrogenase (GAPDH). Values represent means 6
S.E.M (N=3). (E, F) KhES-3 cells cultured for 20 or 30 days were stained for AFP (green) (E) or ALB (red) (F). Nuclei were stained with DAPI (blue). Scale
bars =100 mM. (G) KhES-3 cells cultured for 30 days were stained for both a-antitrypsin (green) and ALB (red). Scale bars =100 mM.
doi:10.1371/journal.pone.0024228.g003
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cell adhesions, were 10% of control levels [35]. Interestingly, this
phenotype could be rescued by HGF in culture, and the authors
suggested that the HGF and Smad signaling pathways might
converge on Igtb1 to promote hepatic development [35].
Itgb1 is implicated in mediating cell behavior in hepatocytes,
including the attachment of hepatocytes to hepatic ECM, thereby
maintaining hepatocyte survival [36]. Transforming growth factor
b has been reported to control the directional migration of
hepatocytes by modulating the expression of Itga5b1 expression
and of its ligand, fibronectin [37], while functional blockade of
Itga5b1 induced cell scattering and spreading [38]. Integrin
expression thus seems to be important for the regulation of
hepatocyte motility in response to cytokine signaling during
embryonic liver development.
The major ECM components LN, collagen IV, HSPG, nidogen
and fibronectin are expressed in the intrahepatic biliary duct from
E13.5 throughout development and after birth [33], and laminin and
collagen types I and IV facilitated the hepatic differentiation of a
subpopulation of hepatic stem cells isolated by flow cytometry [39].
Overall, the BM components appear to be important for hepatic
development. LN expression in humans is observed during embryonic
and fetal development, similar to the situation in mice [40].
This study demonstrates the importance of the BM components
in the differentiation of mouse and human ES cells into the hepatic
lineage. From undifferentiated human ES cells grown on one
90 mm-dish (1610
7 cells), approximately 2610
8 cells of human
ES cell-derived hepatic cells can be generated using the present
sBM system after 30 days culture. Therefore, it is feasible to utilize
this culture procedure to provide a surrogate cell source for
regenerative medicine, as well as for pharmaceutical and
developmental biology studies.
Materials and Methods
ES Cell lines
The mouse ES cell line, SK7 [10] was maintained on mouse
embryonic fibroblast (MEF) feeder cells in Glasgow minimum
Figure 4. Expression of functional hepatocyte markers in differentiated khES-3 cells. (A) Expression of CYP3A4, CYP7A1, NTCP, OATP2B1,
SULT2A1, UGT1A1 and GAPDH in differentiated KhES-3 cells at D10, and D30, in human fetal and adult liver. (B) Albumin secretion by human ES cell-
derived hepatic cells was assayed by ELISA. The differentiation medium was changed to fresh medium 24 hrs before the assay. The amount of
albumin released from the ES cell-derived hepatic cells into the medium per 24 hrs per mg protein was measured at D10, D20, D25 and D30 of
differentiation on sBM. Values represent means 6 S.E.M (N=3). (C) ICG-positive cells were detected at differentiation D30. (D) PAS assay of D30
differentiated ES cells indicated numerous hepatocytes within colonies exhibiting cytoplasmic glycogen storage. (E) CLF-positive cells were detected
at differentiation D30. Scale bars =100 mM (C–E). (F) Treatment with rifampicin for 48 hrs induced both CYP3A4 transcripts (left panel) and CYP3A4
enzyme activity (right panel) in KhES-3-derived hepatic cells. Significant differences were observed (*p,0.05) versus control. Values represent means
6 S.E.M (N=3).
doi:10.1371/journal.pone.0024228.g004
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with 1,000 U/ml leukemia inhibitory factor (Chemicon, Tmme-
cula, CA), 15% KSR (Invitrogen, Carlsband, CA), 1% fetal bovine
serum (FBS; Hyclone, Logan, UT), 100 mM nonessential amino
acids (NEAA; Invitrogen), 2 mM L-glutamine (L-Gln; Nacalai
Tesque, Kyoto, Japan), 1 mM sodium pyruvate (Invitrogen),
50 U/ml penicillin and 50 mg/ml streptomycin (PS; Nacalai
Tesque) and 100 mM b-mercaptoethanol (bME; Sigma-Aldrich) as
described previously [10,41].
Human ES cells (KhES-3) [42] were from Dr. Norio Nakatsuji
and Dr. Hirofumi Suemori (Kyoto University, Kyoto, Japan) and
were used in accordance with the human ES cell guidelines of the
Japanese government. This human ES work was approved by
Kumamoto University institutional review board. Undifferentiated
human ES cells were maintained as described previously [11].
Growth factors and inhibitors
Reagents were purchased and used at the designated concen-
trations as follows: recombinant human activin-A (R&D Systems,
Minneapolis, MN), 20 ng/ml (for mouse ES cells) or 100 ng/ml
(for human ES cells); recombinant human bFGF (Peprotech,
Rocky, NJ), 50 ng/ml; Retinoic acid (RA, Sigma-Aldrich),
10
26 M; recombinant human HGF (Peprotech), 10 ng/ml;
Dexamethasone (Sigma-Aldrich), 1 mM; Dimethylsulfoxide
(DMSO, Sigma-Aldrich), 1% (for mouse ES cells) or 0.5% (for
human ES cells); Nicotinamide (NA, Sigma-Aldrich), 1 mM (for
mouse ES cells) or 0.5 mM (for human ES cells); ascorbic acid
(AsP, Sigma-Aldrich), 0.2 mM; Y-27632 (Rho-associated kinase
inhibitor, Wako Chemical, Osaka, Japan), 10 mM. Akt inhibitor
IV (Calbiochem, Darmstadt, Germany) 1 mM.
sBM preparation
The sBM was prepared as described previously [21]. Mochitate,
K. Method of preparing BM, method of constructing BM
specimen, reconstituted artificial tissue using the BM specimen
and process for producing the same. US Patent number 7,399,634
and 7,906,332. Human LN-511 (rLN-10) derived from 293 cells
was a kind gift from Dr. Masayuki Doi and Dr. Karl Tryggvason
at Karolinska Institute, Sweden [28].
Differentiation of ES cells on sBM substratum into hepatic
lineage
The sBM substratum was stored at 275uC and gently thawed in
a refrigerator one night before use. ES cells grown on MEF were
dissociated and plated at a 5,000 cells per sBM substratum (12-well
culture insert, surface area =0.9 cm
2). For hepatic differentiation,
ES cells were cultured in 4,500 mg/l glucose DMEM containing
insulin (10 mg/l), transferrin (5.5 mg/l), sodium selenite (6.7 mg/
ml) ITS (Invitrogen), ALBUMAX II (2.5 mg/ml) (Invitrogen),
NEAA, L-Gln, PS and bME (ITS-DMEM), supplemented with
activin A (20 ng/ml) and bFGF (50 ng/ml) at D0–D9, and RA
(10
26 M) was added from D9–D11. This was then switched to
2,000 mg/l glucose DMEM containing 10% KSR, NEAA, L-Gln,
PS and bME (KSR-DMEM), supplemented with HGF (10 ng/
ml), Dex (1 mM), DMSO (1%), and NA (1 mM) at D11, then
cultured up to D30.
Human KhES-3 cells were pre-treated with Y-27632, a potent
Rho-kinase inhibitor, for 12 hrs, then dissociated using 0.25%
trypsin-EDTA, and plated at 50,000 cells per sBM substratum. ES
cells were cultured in RPMI-1640 (Invitrogen) supplemented with
activin A (100 ng/ml), B27 supplement (2%) (Invitrogen), NEAA,
L-Gln, PS and bME for 10 days. They were then switched to
hepatic differentiation medium: KSR-DMEM supplemented with
HGF (10 ng/ml), Dex (1 mM), DMSO (0.5%), NA (0.5 mM), and
AsP (0.2 mM) at D10 then cultured up to D30. Medium was
replaced every 2 days with fresh differentiation medium
supplemented with growth factors.
Hepatocyte isolation and culture
Hepatocytes were isolated from the whole liver of an adult ICR
mouse (male, 7–8 weeks old) by the two-step liver perfusion
method of Seglen [43]. Cell viability was determined by trypan
blue exclusion, and cells used were obtained with more than 50%
viability. The culture medium used were consisted of DMEM
supplemented with ITS, PS, L-Gln, 7.5 mg/L hydrocortisone
(Sigma), 50 mg/L epidermal growth factor (Peprotech), 60 mg/L
proline (Sigma), 50 mg/L linoleic acid (Sigma), 0.1 mM CuSO45
H2O (Sigma), 50 pM ZnSO47H 2O (Sigma) [44].
Reverse-transcription polymerase chain reaction (RT-PCR)
and real-time PCR analysis
RNA extraction, RT, PCR analysis, and real-time PCR analysis
were performed as described previously [10,11]. Human fetal (22–
40 weeks old) and adult (51 years old) liver total RNAs were
purchased from Clontech Laboratories, Inc. The primer sequenc-
es for each primer set are shown in Table S1. The PCR conditions
for each cycle were: denaturation at 96uC for 30 sec, annealing at
60uC for 2 sec, and extension at 72uC for 45 sec. RT-PCR
products were separated by 5% non-denaturing polyacrylamide
gel electrophoresis, stained with SYBR Green I (Molecular Probes,
Eugene, NY), and visualized using a Gel Logic 200 Imaging
System (Kodak, Rochester, NY). The real-time PCR conditions
were as follows: denaturation at 95uC for 15 sec, annealing and
extension at 60uC for 60 sec, for up to 40 cycles. Target mRNA
levels were expressed as arbitrary units, and were determined
using the standard curve method.
Immunocytochemistry
For whole-mount immunocytochemical analysis, ES cell
cultures were fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 30 min, followed by permealization with
0.1% Triton-X (Nakalai Tesque) in PBS for 10 min at room
temperature, rinsed several times with PBS then incubated with
diluted antibody in 20% Blocking One (Nacalai Tesque) in PBST
(0.1% Tween-20 in PBS) in a humidified chamber overnight at
4uC. Cells were washed in PBST, and incubated with secondary
antibody in 20% Blocking One for 2 hr at room temperature in
the dark. After washing off the secondary antibody in PBST, cells
were counterstained with 6-diamidino-2-phenylindole (DAPI)
(Roche Diagnostics, Indianapolis, IN). The following antibodies
were used as first antibodies: rabbit anti-AFP (Dako, Glostrup,
Denmark), goat anti-ALB (Sigma-Aldrich), rabbit anti-a-1-anti-
trypsin (Sigma-Aldrich) and goat anti-Sox17 (R&D systems).
Secondary antibodies used were Alexa 568-conjugated and Alexa
488-conjugated antibodies (Invitrogen).
Gene silencing
Expression arrest control shRNA (Open Biosystems,
#RHS4080) or Itgb1 shRNA (Open Biosystems, #RMM3981-
97055034) lentiviral vectors carrying puromycin-resistance genes
were used for Itgb1-knockdown assays. For virus preparation,
HEK293-FT cells (Invitrogen) were plated the day before
transfection. After overnight culture, the cells were transfected
with lentiviral vectors and ViraPower Lentiviral Packaging Mix
(Invitrogen) using FuGENE6 Transfection Reagent (Roche
Diagnostics) for 24 hours, and viral supernatants were collected.
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titration kit (Clonetech). The M.O.I used was 500.
Flow cytometry analysis
The following antibodies were used: biotin-conjugated anti-
Integrin b1 monoclonal antibody (mAb) (BD Biosciences Phar-
mingen), Streptavidin-conjugated APC (BD Biosciences Pharmin-
gen). The stained cells were analyzed with a FACS Canto (BD).
Data were recorded with the BD FACS Diva Software program
(BD) and analyzed using the Flowjo program (Tree Star).
Western Blot
NS or Intgb1 KD cells were homogenized in SDS sample buffer
(62.5 mM Tris-HCl, 10% glycerol, 2% SDS, pH 6.8). After
centrifugation, the supernatants were collected and used as total
protein extracts. Total proteins were subjected to 10% SDS-PAGE
and transferred to polyvinylidene difluoride membranes. The
membranes were incubated with rabbit anti-GAPDH antibody
(Cell Signaling Technology (CST), Beverly, MA) at 1:1000
dilutions, rabbit anti-Akt antibody (CST) at 1:1000 dilution, or
rabbit anti-Phospho Akt antibody (CST) at 1:1000 dilution.
Horseradish-peroxidase-conjugated anti- rabbit Ig (CST) was used
as a secondary antibody at 1:20,000 dilutions, and chemilumines-
cent signals were detected with ECL Plus western blotting
detection reagents (GE Healthcare, Chalfont Saint Giles, UK).
Albumin secretion assay
Culture medium was replaced 1 day prior to the assay with
0.5 ml/1.0 ml fresh medium in the upper/lower compartment of
sBM (12-well culture insert, surface area =0.9 cm
2). Conditioned
medium was harvested 24 hrs later and assayed for albumin
secretion using an enzyme-linked immunosorbent assay (ELISA)
kit (Bethyl, Montgomery, TX). Albumin secretion levels were
normalized with total protein of differentiated ES cells at each
sampling point. The protein amounts were calculated using Bio
Rad Protein Assay Kit (Bio Rad, Hercules CA).
Indocyanine green (ICG) test
ICG (Daiichi-Sankyo Pharma, Tokyo, Japan) was diluted in the
above culture medium to a final concentration of 1 mg/ml. The
ICG test solution was added to the differentiated ES cells on D30,
and incubated at 37uC for 30 mins. Cells were washed three times
with PBS, and the cellular uptake of ICG was then examined by
microscopy.
PAS analysis
The cultured cells were fixed in 3.3% formalin for 10 mins, and
intracellular glycogen was stained using a PAS staining solution
(Muto Pure Chemicals, Tokyo, JAPAN), according to the
manufacturer’s instructions.
Cholyl lysyl fluorescein (CLF) staining
The cells were rinsed with PBS, and 5 mM CLF (BD
Biosciences, San Diego, CA) in medium was added. After
incubation for 30 mins, the cell cultures were rinsed with PBS.
Cell morphology and CLF accumulation in bile canaliculi-like
structure were assessed by phase-contrast and fluorescence
microscopy.
CYP3A4 activity
To check the inducibilities of cytochrome P450 activities in
response to inducers, we used a P450-Glo
TM CYP Assay Kit
(Promega, Madison, WI). The differentiated ES cells were treated
with 10 mM rifampicin as an inducer of CYP3A4. Medium
containing the inducer was changed every 24 hrs. The medium
was changed 48 hrs after treatment, and the appropriate
luminogenic CYP substrates were added [Luciferin-Penta Fluoro
Benzyl Ether (PFBE) for CYP3A4]. The cells were incubated at
37uC for 3 hrs, and the supernatants were then mixed with equal
amount of Detection Reagent, according to the manufacturer’s
instructions (Promega). The luminescence was measured using a
GloMax 96 microplate luminometer (Promega), using luminom-
eter settings according to the manufacturer’s instructions.
Supporting Information
Figure S1 Flow cytometry of differentiated ES ells
grown on sBM on D9. Left panel: unstained negative control.
Right panel: 40% of total ES cells were E-cadherin+/CXCR4+
definitive endoderm cells.
(TIF)
Figure S2 Dose dependent death of differentiated ES
cells by puromycin. ES cells were cultured as described in Fig.
1 and 0.5, 1.0 or 1.5 mg/ml puromycin were added from D10 to
D11. On D11, cells were harvested and counted.
(TIF)
Table S1 PCR primers used to detect mouse gene
expressions.
(PDF)
Table S2 Comparison of albumin secretion levels
among different culture conditions.
(TIF)
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